Charles River Laboratories Intl. Inc vs VICI Properties Inc — how do they compare? Charles River Laboratories Intl. Inc trades at $287.99 (market cap $13.46B), while VICI Properties Inc trades at $25.98 (market cap $28.61B). The key difference: VICI Properties Inc is far larger — about 2.1× Charles River Laboratories Intl. Inc's market cap, and VICI Properties Inc pays a 6.93% dividend while Charles River Laboratories Intl. Inc pays none. Which is the better fit depends on your goals.
| CRL | VICI | |
|---|---|---|
Market Cap | $13.46B | $28.61B |
Sector | Health | Real Estate |
52-Week High | $282.00 | $33.78 |
52-Week Low | $145.57 | $25.94 |
Enterprise Value | $16.30B | $46.16B |
Dividend Yield | — | 6.93% |
Trailing returns across standard periods
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →VICI Properties is an S&P 500 experiential real estate investment trust (REIT) that owns one of the largest portfolios of market-leading gaming, hospitality, and entertainment destinations, including Caesars Palace and MGM Grand. It utilizes a long-term, triple-net lease model to provide stable, inflation-protected income, serving as the primary landlord for the 'experience economy' while diversifying into non-gaming sectors like wellness, youth sports, and luxury resorts.
Read more on VICI →